Perspective Therapeutics (CATX) Long-Term Investments (2016)

Perspective Therapeutics' Long-Term Investments history spans 3 years, with the latest figure at $3.0 million for Q2 2016.

  • On a quarterly basis, Long-Term Investments fell 41.78% to $3.0 million in Q2 2016 year-over-year; TTM through Jun 2016 was $3.0 million, a 41.78% decrease, with the full-year FY2016 number at $3.0 million, down 41.78% from a year prior.
  • Long-Term Investments hit $3.0 million in Q2 2016 for Perspective Therapeutics, down from $5.2 million in the prior quarter.
  • Over the last five years, Long-Term Investments for CATX hit a ceiling of $5.4 million in Q2 2014 and a floor of $3.0 million in Q2 2016.
  • Historically, Long-Term Investments has averaged $4.8 million across 3 years, with a median of $5.2 million in 2015.
  • Biggest five-year swings in Long-Term Investments: fell 5.45% in 2015 and later plummeted 41.78% in 2016.
  • Tracing CATX's Long-Term Investments over 3 years: stood at $5.4 million in 2014, then fell by 4.4% to $5.2 million in 2015, then plummeted by 42.42% to $3.0 million in 2016.
  • Business Quant data shows Long-Term Investments for CATX at $3.0 million in Q2 2016, $5.2 million in Q1 2016, and $5.2 million in Q4 2015.